These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7717895)

  • 21. Clinical and prognostic values of anti-hepatitis B core immunoglobulin M detection in asymptomatic hepatitis B surface antigen carriers.
    Ali HY; Faransawy ZE; Al-Megthab NA
    Saudi Med J; 2002 Jul; 23(7):777-81. PubMed ID: 12174223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up of hepatitis B virus carriers with normal transaminases levels.
    Koçak N; Ozen H; Yüce A; Gürakan F
    Turk J Pediatr; 1998; 40(3):365-72. PubMed ID: 9763900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A qualitative study of health-seeking behavior of Hepatitis B carriers.
    Tan NC; Cheah SL; Teo EK
    Singapore Med J; 2005 Jan; 46(1):6-10. PubMed ID: 15633001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus.
    Chu CM; Liaw YF
    Am J Gastroenterol; 2009 Jul; 104(7):1693-9. PubMed ID: 19455130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The natural course of hepatitis B and hepatitis C virus infection].
    Schwabe RF; Stremmel W
    Praxis (Bern 1994); 1998 Oct; 87(42):1403-7. PubMed ID: 9824947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Asymptomatic carriers of HBsAg: is a follow-up necessary?].
    Vignote ML; Gómez-Camacho F; Poyato A; González R; Palomo D; Hervás A; Peña J; Miño G
    Rev Esp Enferm Dig; 1995 Oct; 87(10):715-9. PubMed ID: 8519537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis.
    Hsu HY; Chang MH; Ni YH; Lin HH; Wang SM; Chen DS
    Hepatology; 1997 Sep; 26(3):786-91. PubMed ID: 9303514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
    Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M
    Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural history of chronic type B hepatitis.
    Hoofnagle JH; Seeff LB
    Prog Liver Dis; 1982; 7():469-79. PubMed ID: 7111756
    [No Abstract]   [Full Text] [Related]  

  • 30. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.
    Huo TI; Wu JC; Lee PC; Chau GY; Lui WY; Tsay SH; Ting LT; Chang FY; Lee SD
    Hepatology; 1998 Jul; 28(1):231-6. PubMed ID: 9657117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the hepatitis B mass vaccination program in the southern part of Thailand.
    Chub-uppakarn S; Panichart P; Theamboonlers A; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):464-8. PubMed ID: 10437940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy of chronic hepatitis B with interferon].
    Vogel W
    Wien Med Wochenschr; 1993; 143(16-17):458-60. PubMed ID: 8273372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intramuscular natural beta interferon in the treatment of chronic hepatitis B: a multicentre trial. Italian Hepatitis B Study Group.
    Capalbo M; Palmisano L; Bonino F; Pellas C; Maset J
    Ital J Gastroenterol; 1994 Jun; 26(5):238-41. PubMed ID: 7919465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression. A prospective cohort study.
    Zacharakis G; Koskinas J; Kotsiou S; Tzara F; Vafeiadis N; Papoutselis M; Maltezos E; Sivridis E; Papoutselis K
    J Hepatol; 2008 Dec; 49(6):884-91. PubMed ID: 18674840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo-controlled trial.
    Bahrami H; Daryani NE; Haghpanah B; Moayyeri A; Moghadam KF; Mirmomen S; Kamangar F
    Am J Gastroenterol; 2005 Apr; 100(4):856-61. PubMed ID: 15784032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C.
    Idilman R; De MN; Colantoni A; Nadir A; Van Thiel DH
    Am J Gastroenterol; 2002 Feb; 97(2):435-9. PubMed ID: 11866284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural history of hepatitis B in perinatally infected carriers.
    Boxall EH; Sira J; Standish RA; Davies P; Sleight E; Dhillon AP; Scheuer PJ; Kelly DA
    Arch Dis Child Fetal Neonatal Ed; 2004 Sep; 89(5):F456-60. PubMed ID: 15321970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment problems in chronic hepatitis].
    Chernev K
    Vutr Boles; 1982; 21(1):6-12. PubMed ID: 6178223
    [No Abstract]   [Full Text] [Related]  

  • 39. [Current problems of viral hepatitis].
    Boroń P
    Przegl Epidemiol; 1981; 35(3):339-49. PubMed ID: 7330243
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparative characteristics of the outcome of hepatitis A and B and the problems of dispensary treatment].
    Ketiladze ES; Farber NA; Ambrozaĭtis AK
    Klin Med (Mosk); 1983 Aug; 61(8):71-5. PubMed ID: 6645356
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.